Drug Shortage Report for RIVA-VALACYCLOVIR
Report ID | 223689 |
Drug Identification Number | 02316447 |
Brand name | RIVA-VALACYCLOVIR |
Common or Proper name | Riva-Valacyclovir |
Company Name | LABORATOIRE RIVA INC. |
Market Status | MARKETED |
Active Ingredient(s) | VALACYCLOVIR |
Strength(s) | 500MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | J05AB |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2024-03-27 |
Actual start date | 2024-03-27 |
Estimated end date | 2025-01-31 |
Actual end date | 2025-01-17 |
Shortage status | Resolved |
Updated date | 2025-02-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 660 BOUL. INDUSTRIEL BLAINVILLE, QUEBEC CANADA J7C 3V4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2025-02-03 | French | Compare |
v7 | 2025-02-03 | English | Compare |
v6 | 2024-12-20 | French | Compare |
v5 | 2024-12-20 | English | Compare |
v4 | 2024-03-28 | English | Compare |
v3 | 2024-03-27 | French | Compare |
v2 | 2024-03-27 | English | Compare |
v1 | 2024-03-27 | English | Compare |
Showing 1 to 8 of 8